Marc Hubert Mercken,Marc Maria Pierre Vandermeeren
申请号：
US15142075
公开号：
US09939452B2
申请日:
2016.04.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This invention relates to antibodies, including specified portions or variants, specific for at least the human Amyloid-beta_11 N-terminal site, i.e. Aβ11-x peptides. It further provides methods of making and using said antibodies, including therapeutic formulations, administration and devices.
